Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jeksung for Radiotherapy-Induced Oral Mucositis
NCT05364918Phase 3Completed
- Sponsor
- Cancer Center of Guangzhou Medical University
- Start
- Aug 2020
- Primary completion
- Aug 2022
- Countries
- 1
01
Overview
Phase 3, randomised trial of triamcinolone acetonide in oral mucositis (OM) (2 arms), sponsored by Cancer Center of Guangzhou Medical University. Primary endpoint: Acute radiotherapy-induced oral mucositis. Started Aug 2020; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT05364918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05364918.